首页> 外文期刊>Circulation research: a journal of the American Heart Association >Mesenchymal Stem Cell-Derived IL-10 and Recovery From Infarction: A Third Pitch for the Chord
【24h】

Mesenchymal Stem Cell-Derived IL-10 and Recovery From Infarction: A Third Pitch for the Chord

机译:间充质干细胞来源的IL-10和从梗死中恢复:弦的第三个音高。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mesenchymal stem cells (MSCs) are multipotent cells found in several adult tissues that are capable of differentiating into a number of different mesenchymal tissues, including muscle, bone, adipose tissue, cardiac myocytes,and neural precursors. When transplanted into allogeneictissues, these cells may persist for long periods of time, suggesting that they can evade immune surveillance and contribute to the repair of damaged tissues. Unfractionated or minimally refined bone marrow cell preparations, which probably contain a mixture of hematopoeitic, mesenchymal, and endothelial precursor cells in addition to dendritic cells, can reduce myocardial infarct size and improve performance after infarction, both in rodent models and in human clinical trials, although the exact extent to which these cells form new cardiac myocytes and promote long-term improvement in functional capacity is still hotly debated.
机译:间充质干细胞(MSCs)是在几种成年组织中发现的多能细胞,能够分化为许多不同的间充质组织,包括肌肉,骨骼,脂肪组织,心肌细胞和神经前体。当移植到同种异体组织中时,这些细胞可能会持续很长一段时间,这表明它们可以逃避免疫监视,并有助于修复受损的组织。除树突状细胞外,未分化或纯化程度最低的骨髓细胞制剂可能还包含造血,间充质和内皮前体细胞的混合物,在啮齿动物模型和人类临床试验中,均可以减少心肌梗塞的大小并改善梗塞后的性能,尽管这些细胞形成新的心肌细胞并促进功能能力长期改善的确切程度仍是热门话题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号